We are live on
!
Find out more
Skandinaviska Enskilda Banken (SEB) Portfolio holdings
AUM
$2.66B
1-Year Est. Return
26.2%
This Quarter
Est. Return
+5.84%
1 Year Est. Return
+26.2%
3 Year Est. Return
+111.17%
5 Year Est. Return
+154.66%
10 Year Est. Return
+614.64%
AUM
$11B
AUM Growth
+$640M
(+6.1%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
24.19%
Holding
767
New
23
Increased
358
Reduced
116
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$263M |
| 2 |
AT&T
T
|
+$112M |
| 3 |
CA
CA, Inc.
CA
|
+$87.9M |
| 4 |
CenterPoint Energy
CNP
|
+$74.4M |
| 5 |
GAP
The Gap Inc
GAP
|
+$48.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$159M |
| 2 |
Southwest Airlines
LUV
|
+$99M |
| 3 |
Magna International
MGA
|
+$63.8M |
| 4 |
Parker-Hannifin
PH
|
+$60.2M |
| 5 |
Philip Morris
PM
|
+$59.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.17% |
| 2 | Technology | 17.77% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Financials | 12.86% |
| 5 | Communication Services | 7.58% |
Similar funds
PCIG
SFI
MG
CCM
TCAM
ACM
VA
MMEA
Skandinaviska Enskilda Banken (SEB)'s Q3 2017 Portfolio in Review
As of Q3 2017, Skandinaviska Enskilda Banken (SEB) held 767 positions worth $11B, up 6.1% from $10.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Skandinaviska Enskilda Banken (SEB)'s Q3 2017 filing shows 23 new, 358 increased, 116 reduced and 41 closed positions. Its largest new stake was Accendra Health: 1,599,600 shares worth $46.7M. The largest sale was HCA Healthcare, an estimated $159M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Skandinaviska Enskilda Banken (SEB)'s largest Q3 2017 buy was Accendra Health: 1,599,600 shares worth $46.7M.
- Skandinaviska Enskilda Banken (SEB) added most to Gilead Sciences in Q3 2017, an estimated $263M increase.
- Skandinaviska Enskilda Banken (SEB)'s biggest Q3 2017 reduction was HCA Healthcare, cutting an estimated $159M.
- Skandinaviska Enskilda Banken (SEB) fully exited DuPont de Nemours in Q3 2017, selling an estimated $34.4M.
- Skandinaviska Enskilda Banken (SEB)'s ten largest holdings make up 24% of its $11B portfolio in Q3 2017.
- Skandinaviska Enskilda Banken (SEB) opened 23 new positions and closed 41 in Q3 2017.
- Skandinaviska Enskilda Banken (SEB)'s portfolio value rose 6.1% quarter-over-quarter to $11B.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2017, filed 13 Nov 2017.